SMPD1 as a Potential Prognostic Biomarker in Glioma Is Associated With an Immunosuppressive Microenvironment. [PDF]
Xu Y +6 more
europepmc +1 more source
Transcortical versus transsylvian approaches for adult insular glioma resection: a systematic review with subanalysis by Berger-Sanai segmentation. [PDF]
Baratti Rocha GW +10 more
europepmc +1 more source
IDH1 Mutant Glioma Favors Group 3 Innate Lymphoid Cells and Is Resistant to Immune Checkpoint Expression. [PDF]
Erdem S +8 more
europepmc +1 more source
Engineered exosomes for targeted glioma therapy: overcoming the blood-brain barrier with nature-inspired nanocarriers. [PDF]
Rahmani P +9 more
europepmc +1 more source
Ivosidenib treatment in IDH-mutant WHO grade 4 astrocytomas: illustrative case. [PDF]
Adjei BO +7 more
europepmc +1 more source
Fluid Suppression Techniques Combined With Amide Proton Transfer-Weighted Imaging for the Evaluation of Adult-Type Diffuse Gliomas. [PDF]
Zhu H +10 more
europepmc +1 more source
Dysregulation of post-translational modifications in glioma: advances in pathological mechanisms and clinical targeting strategies. [PDF]
Wu J +9 more
europepmc +1 more source
RETRACTION: Fermented Mistletoe Extract as a Multimodal Antitumoral Agent in Gliomas. [PDF]
And Alternative Medicine EC.
europepmc +1 more source
From Classical to Emerging Biomarkers of Brain and Central Nervous System Tumors. An Evidence-Based Review with a Focus on Gliomas. [PDF]
Ortega MA +16 more
europepmc +1 more source

